Keyword: Teva

News

Teva Intends to Divest API Business

02.02.2024 -

Israeli generics manufacturer Teva Pharmaceuticals intends to divest its active pharmaceutical ingredient (API) business, Teva API (TAPI). A standalone business unit of...

News

Sanofi Enters into Partnerships with Janssen and Teva

04.10.2023 -

Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize the vaccine candidate for...

News

Flamma Invests $200 Million to Expand CDMO Capabilities

23.03.2023 -

Italian CDMO Flamma Group intends to invest $200 million over the next three years to expand its capabilities to meet growing market demand.

News

Generic Price-fixing Probe may See Progress

27.11.2019 - Israeli generics giant Teva Pharmaceuticals and other generic drugmakers have been discussing possible settlements with US federal prosecutors in a long-running price-fixing probe...

News

Reckitt Settles Opioid Case, Teva Deal Questioned

25.10.2019 - Another US opioid maker has moved to settle charges against it out of court. Reckitt Benckiser will pay $700 million to settle six states' claims that its former Indivior business...

News

Ohio Settles with Four US Opioid Players

22.10.2019 - After negotiating through the night, Israeli generics giant Teva – which is a leading supplier of the US market – and the three biggest US drug distributors on Oct. 21 reached a...

News

US Opioid Settlement Talks in High Gear

17.10.2019 - Long anticipated bundled proceedings against opioid manufacturers and US opioid distributors began on Oct. 16 in a US court in Cleveland, Ohio, where cases against Israeli generics...

Strategy & Management

Continuous Processing

10.09.2019 - Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...